Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: Correlation with clinical features

BMC Cancer

Volumn 2, Issue , 2002, Pages

  Feng, Chang Wei ^a   Wang, Li Dong ^a,b   Jiao, Lian Hua ^a   Liu, Bin ^c   Zheng, Shu ^b   Xie, Xin Ji ^c  

^a ZHENGZHOU UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; BIOTIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXIDASE; PROTEIN P53; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN; SIGNAL PEPTIDE; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CHINA; CHRONIC GASTRITIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; DYSPLASIA; FEMALE; HEALTH SURVEY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRECANCER; PROTEIN EXPRESSION; RANDOMIZATION; STATISTICAL SIGNIFICANCE; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOMA; STOMACH WALL; TUMOR DIFFERENTIATION; ADENOCARCINOMA; CHEMISTRY; CLINICAL TRIAL; CYTOLOGY; ENZYMOLOGY; IMMUNOLOGY; MASS SCREENING; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHYSIOLOGY; STOMACH MUCOSA; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; CHINA; ENDOTHELIAL GROWTH FACTORS; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MASS SCREENING; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038325098     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-2-8     Document Type: Article

References (20)

1. Ambs S, Bennet WP, Marriam WG, Ogunfusika MO, Oser SM, Khan MA, et al: Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Br J Cancer 1994, 59:514-519
2. Ambs S, Marriam WG, Bennet WP, Felley-bosco E, Ogunfusika MO, Oser SM, et al: Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998, 58:334-341
3. Ambs S, Bennet WP, Marriam WG, Ogunfusika MO, Oser SM, Anita M, et al: Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. JNCI 1999, 91:86-88
4. Chiarugi V, Magnelli L, Gallo O: Cox-2, iNOS and p53 as playmarkers of tumor angiogenesis (review). Int J Mol Med 1998, 2:715-719
5. Correa P: Human gastric carcinogenesis. A multistep and multifactorial process-first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992, 52:6735-6740
6. Devavrata M, Leonidas T, Vikas PS: Wild-type p53 and v-src exert opposing influence on human vascular endothelial growth factor gene expression. Cancer Res 1995, 55:6161-6167
7. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC, et al: Nitric oxide induced p53 accumulation and regulation of inducible nitric oxide synthase (iNOS) expression by wild-p53. Natl Acad Sci USA 1996, 93:2442-2447
8. Jekins DC, Charles LC, Thomsen LL, Moss DW, Holmes LS, Bayles SA, et al: Roles of nitric oxide in tumor growth. Natl Acad Sci USA 1995, 92:4393-4396
9. Nomura A: Stomach cancer. In: Cancer epidemiology and prevention (Edited by: Schottenfeld D and Fraumeni JF, eds) New York, Oxford University Press 1996, pp707-720
10. Parkin DM, Muir C, Whelan SL, Gao YT, Ferlay J, Powell J, eds: Cancer incidence in five continents. In: Vol. VI Lyon, IARC Scientific Publications 1992, 120:
11. Wang LD, Shi ST, Zhou Q, Goldstin S, Hong JY, Shao P, et al: Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer 1994, 59:514-519
12. World Health Organization: 1994. World Health Statistics Annual. Geneva: world Health Organization 1994, pp396-407
13. You WC, Blot WJ, Li JY, Chang YS, Jin ML, Kneller R, et al: Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 1993, 53:1317-1321
14. Zhang LL, Yu D, Xiong SB, Lang A, Ellis LM, Pollock RE: Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res 2000, 60:3661-3665
15. Maehara Y, Kabashima A, Koga T, Tokunaga E, Takeuchi H, Kakeji Y, Sugimachi K, et al: Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery 2000, 128:408-416
16. Sakatani T, Okamoto E, Tsujitani S, Ikeguchi M, Kaibara N, Ito H, et al: Expression of thymidine phosphorylase (dThdPase) and vascular endothelial growth factor on angiogenesis in intestinal-type gastric carcinoma. Oncol Rep 2000, 7:831-836
17. Ikeguchi M, Oka S, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N, et al: Nuclear accumulation of p53 protein in gastric cancer strongly correlated with enlargement of nuclear area of cancer cells. Oncol Rep 2000, 7:579-584
18. Saito H, Tsujitani S, Ikeguchi M, Maeta M, Kaibara N, et al: Neoangiogenesis and relationship to nuclear p53 accumulation and vascular endothelial growth factor expression in advanced gastric carcinoma. Oncology 1999, 57:164-172
19. Maeda K, Kang SM, Onoda N, Ogawa M, Sawada T, Nakata B, Kato Y, Chung YS, Sowa M, et al: Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer. Oncology 1998, 55:594-599
20. Rajnakova A, Moochhala S, Goh PM, Ngoi S, et al: Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett 2001, 172:177-185